Total Alive Death or ICU p value
Number of patients 100 64 36 -
Oxygen therapy FiO2 Oxygen therapy FiO2 Oxygen therapy FiO2 Oxygen therapy FiO2 Oxygen therapy FiO2
FiO2 on admission 21% 30% 40% 50% 100% 54 (54%) 29 (29%) 7 (7%) 4 (4%) 6 (6%) 42 (66%) 14 (22%) 6 (9%) 1 (2%) 1 (2%) 12 (33%) 15 (42%) 1 (3%) 3 (8%) 5 (14%)
0.001
Highest FiO2 during admission 21% 30% 40% 50% 100% High flow oxygen 32 (32%) 26 (27%) 10 (10%) 5 (5%) 21 (21%) 4 (4%) 28 (44%) 20 (31%) 8 (12%) 2 (3%) 4 (6%) 2 (3%) 4 (12%) 6 (18%) 2 (6%) 3 (9%) 17 (50%) 2 (6%)
<0.001
Prone positioning 5 (5%) 0 (0%) 5 (14%) 0.002
Medical treatment
Only symptomatic 31 (31%) 18 (28%) 13 (36%) 0.41
Medication† 69 (69%) 46 (72%) 23 (64%)
Azithromycin HCQ + azithromycin HCQ + azithromycin + Lopinavir/r 2 (3%) 66 (96%) 1 (1%) 0 (0%) 46 (100%) 0 (0%) 2 (9%) 20 (87%) 1 (4%)
0.04
Days from the onset of symptoms to start of treatment 9 [4] 9 [4] 7 [7] 0.08
Intravenous antibiotics 26 (26%) 13 (20%) 13 (36%) 0.08
Glucocorticoids 12 (12%) 6 (9%) 6 (17%) 0.28